A role for ETV1 and endothelial cell-derived extracellular vesicle microRNAs in priming fibroblast response to vesicle-bound FGF2

This study elucidates how endothelial cell-derived extracellular vesicles, through the transcription factor ETV1 and specific microRNAs, prime dermal fibroblasts to undergo a transcriptomic and phenotypic shift resembling FGF2-mediated cancer-associated fibroblast activation, thereby defining a key mechanism in cutaneous wound repair.

The Gist

Imagine your body is a bustling city, and when you get a cut (a wound), it's like a construction site has opened up. To fix the damage, the city needs different teams to work together: the plumbers (endothelial cells that build new blood vessels) and the construction workers (fibroblasts that build the new skin and tissue).

For a long time, scientists knew these teams needed to talk to each other to fix the wound properly, but they didn't know exactly how they were sending messages. This paper reveals the secret communication channel they use: tiny, bubble-like packages called "Extracellular Vesicles" (ECEVs).

Here is the story of how the plumbers talk to the construction workers, explained simply:

1. The Messenger Bubbles

Think of the endothelial cells (plumbers) as a factory that packs tiny bubbles (vesicles) and shoots them toward the fibroblasts (construction workers). These bubbles aren't empty; they are packed with two very important things:

• A specific instruction manual (FGF2): A protein that tells the workers, "Hey, start building and growing!"
• A set of "Do Not Disturb" signs (MicroRNAs): Tiny genetic snippets that tell the workers to ignore certain signals that would make them stop working or build too much scar tissue.

2. The Foreman: ETV1

Once the fibroblast receives one of these bubbles, it needs a foreman to read the instructions and get the crew moving. That foreman is a protein called ETV1.

• The Experiment: The scientists played a trick on the construction workers. They removed the foreman (ETV1) from the fibroblasts.
• The Result: Without the foreman, even though the bubbles arrived with the "Start Building" instructions, the workers just stood around doing nothing. They didn't multiply, and they didn't start remodeling the tissue.
• The Lesson: The bubble is useless without the foreman. ETV1 is the essential switch that turns the "growth" signal on.

3. The "Do Not Disturb" Signs (MicroRNAs)

The bubbles also carry a cargo of tiny genetic messages called microRNAs. The scientists found that the most common one is called miR-126-3p.

• The Problem: Normally, there's a signal in the body (TGF-β1) that tells fibroblasts to stop growing and start making stiff, messy scar tissue. This is like a "Stop Work" order that leads to bad scarring.
• The Solution: The bubbles deliver the microRNAs, which act like "Do Not Disturb" signs. They specifically target the "Stop Work" orders and silence them.
• The Twist: The scientists tried to give the workers just the microRNA (without the bubble or the FGF2 protein). Surprisingly, it didn't make them grow faster. It actually slowed them down.
• The Big Reveal: The microRNAs alone aren't the "growth engine." Instead, they are the pruning shears. They cut away the "Stop Work" signals, clearing the path so that when the "Start Building" signal (FGF2) arrives, the workers can do their job efficiently without getting confused or making a mess.

4. The Two-Pronged Strategy

So, how does the healing actually happen? The paper describes a clever two-step strategy used by the endothelial cells:

1. The Gas Pedal: The bubble delivers FGF2, which activates the foreman (ETV1). This tells the fibroblast, "Go! Multiply! Build!"
2. The Brake Release: The bubble delivers microRNAs, which silence the "Stop" signals (TGF-β1). This ensures the fibroblast doesn't accidentally build a scar or stop too early.

Why This Matters

Think of wound healing like driving a car.

• FGF2/ETV1 is you pressing the gas pedal.
• The MicroRNAs are someone taking your foot off the brake.

If you only press the gas but keep your foot on the brake, the car won't move (or it will move poorly). If you only take your foot off the brake but don't press the gas, the car sits still. You need both to drive forward smoothly.

In summary: This paper discovered that endothelial cells send a "care package" to skin cells. This package contains a "Go" signal and a "Stop the Stop" signal. Together, they reprogram the skin cells to heal the wound quickly and cleanly, rather than forming a messy scar. Understanding this helps scientists figure out how to fix wounds that aren't healing or scars that are too ugly.

Technical Summary

1. Problem Statement

Effective wound healing and tissue regeneration rely on complex paracrine communication between cell types, specifically between endothelial cells (ECs) and fibroblasts. While it is established that endothelial cell-derived extracellular vesicles (ECEVs) facilitate this communication, the precise molecular mechanisms remain unclear. Previous work by the authors suggested that ECEVs induce a gene signature in dermal fibroblasts resembling cancer-associated fibroblasts (CAFs), driven by vesicle-bound Fibroblast Growth Factor 2 (FGF2) and the transcription factor ETV1. However, the specific mechanistic role of ETV1 in mediating these effects and the contribution of ECEV cargo (specifically microRNAs) to this process were not fully defined.

2. Methodology

The study employed a combination of in vitro cell culture, molecular biology techniques, and bioinformatics to dissect the ECEV-fibroblast interaction:

• ECEV Isolation: Primary human dermal microvascular endothelial cells were cultured in exosome-free media. ECEVs were isolated from the conditioned media using a polyethylene glycol (PEG)-based precipitation method.
• Loss-of-Function Studies (ETV1): Primary human dermal fibroblasts were transfected with ETV1 siRNA to achieve knockdown. Efficiency was verified via RT-PCR (48h) and Western Blot (72h).
• Functional Assays:
  • Proliferation: Measured using CCK-8 and MTS assays following ECEV treatment in control vs. ETV1-knockdown fibroblasts.
  • Migration: Assessed using silicone culture inserts (wound healing assay) and ImageJ analysis.
  • Gene Expression: RT-PCR was used to quantify mRNA levels of ECM genes (e.g., ACTA2, COL1A2, COL3A1, FN1, ELN, MMP1) and the miRNA target ITGA11.
• MicroRNA Analysis:
  • Sequencing: Small RNA sequencing (Illumina SE50) was performed on isolated ECEVs to identify the top abundant miRNAs.
  • Mimic Transfection: Fibroblasts were transfected with mimics of top ECEV miRNAs (e.g., miR-126-3p) to test if individual miRNAs could recapitulate ECEV effects.
  • Transfer Verification: RT-PCR quantified miR-126-3p levels in fibroblasts at 4h and 24h post-ECEV treatment to confirm vesicle-mediated delivery.
• Bioinformatics: Ingenuity Pathway Analysis (IPA) was used to predict interactions between the top 30 ECEV miRNAs and TGF-β1-associated genes known to be downregulated in ECEV-treated fibroblasts.
• Statistical Analysis: Data were analyzed using t-tests, one-way or two-way ANOVA with Bonferroni post-hoc tests (GraphPad Prism).

3. Key Contributions

• Mechanistic Definition of ETV1: The study definitively establishes ETV1 as a critical mediator required for ECEV-induced fibroblast proliferation and specific ECM gene regulation.
• Dual-Mechanism Model: The authors propose a "two-pronged" mechanism where ECEVs act via:
  1. Protein Cargo: Vesicle-bound FGF2 driving ETV1 upregulation.
  2. RNA Cargo: Coordinated miRNA delivery that primes fibroblasts by repressing TGF-β1 signaling, thereby enhancing sensitivity to FGF2.
• miRNA Cargo Characterization: Identification of the top 5 ECEV miRNAs (hsa-miR-126-3p, hsa-miR-151a-3p, hsa-miR-99a-5p, hsa-miR-21-5p, hsa-miR-221-3p) and the demonstration that they act cooperatively rather than individually to modulate fibroblast phenotype.

4. Key Results

• ETV1 is Essential for Proliferation: Knockdown of ETV1 (>90% mRNA reduction) significantly attenuated the proliferative response of fibroblasts to ECEVs. Control cells showed enhanced proliferation with ECEVs, whereas ETV1-depleted cells did not.
• Selective Regulation of ECM Genes: ETV1 knockdown partially reversed the ECEV-induced downregulation of fibrotic/contractile genes (ACTA2, COL1A3, COL3A1, FN1), but had no effect on ELN or MMP1. This indicates ETV1 selectively mediates the suppression of TGF-β1-driven fibrotic genes.
• Individual miRNAs are Insufficient: Transfection of fibroblasts with miR-126-3p mimics (the most abundant ECEV miRNA) actually decreased proliferation and migration. Similar negative effects were seen with other top miRNAs. This suggests that individual miRNAs cannot drive the ECEV phenotype alone.
• Cooperative miRNA Repression: In silico analysis revealed that the top 30 ECEV miRNAs collectively target and are predicted to repress 5 out of 8 TGF-β1-associated genes. This collective repression creates a permissive environment (anti-TGF-β1, pro-FGF2) for fibroblast activation.
• Functional miRNA Transfer: Levels of miR-126-3p significantly increased in fibroblasts 4h and 24h after ECEV treatment, confirming efficient vesicle-mediated transfer. Consequently, the target gene ITGA11 (a TGF-β1 associated gene) was downregulated in ECEV-treated fibroblasts.

5. Significance

This study elucidates a sophisticated communication pathway in wound healing where endothelial cells "reprogram" fibroblasts via extracellular vesicles. The findings highlight that:

1. Synergy is Key: The functional outcome (fibroblast proliferation and ECM remodeling) is not driven by a single molecule but by the synergistic action of protein growth factors (FGF2) and a cocktail of miRNAs.
2. Priming Mechanism: ECEV miRNAs act as "primers" by suppressing the TGF-β1 pathway (typically associated with fibrosis), thereby shifting the fibroblast genotype to be more responsive to FGF2-mediated proliferation and regeneration.
3. Therapeutic Potential: Understanding this ETV1/miRNA axis offers new targets for modulating wound healing, potentially to prevent excessive fibrosis (scarring) or to enhance regeneration in chronic wounds.

Limitations Noted by Authors:

• The use of transient transfection limits long-term studies (e.g., ECM deposition).
• miRNA-mRNA predictions are inferential and require validation via high-resolution methods like CLIP-seq.
• Detection of miRNA transfer was limited to highly abundant miRNAs; more sensitive methods might reveal transfer of lower-abundance miRNAs.